Recent Posts on This Topic | See All >
[Source: Inside Tucson Business] - Innovative drug development research that could lead to the creation of new medications are under development by three University of Arizona researchers due to a new $1.1 million grant from the National Institutes of Health (NIH).
The three-year grant supports small molecule drug development advancements that could lead to new drugs for cancer, diabetes, and other diseases.
For more information: $1.1 million grant for drug development
Now available: “Action and Impact," a 2014 report on the grant programs and activities of the Flinn Foundation in Arizona biosciences, civic leadership, arts and culture, and the Flinn Scholars program.